Investigation of Magnesium-Based Interventions for Central and Peripheral Nervous Tissue Regeneration

Total Page:16

File Type:pdf, Size:1020Kb

Investigation of Magnesium-Based Interventions for Central and Peripheral Nervous Tissue Regeneration Investigation of Magnesium-based Interventions for Central and Peripheral Nervous Tissue Regeneration A dissertation submitted to the Division of Research and Advanced Studies of the University of Cincinnati in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY (Ph.D.) In the Department of Biomedical Engineering Of the College of Engineering and Applied Science February 2013 by John James Vennemeyer B.S., University of Cincinnati, Cincinnati, OH 2008 Dissertation Committee Sarah K. Pixley, Ph.D., Committee Chair, Associate Professor, Department of Cancer Biology, College of Medicine, University of Cincinnati. Joseph F. Clark, Ph.D., Professor, Department of Neurology, College of Medicine, University of Cincinnati. Daria A. Narmoneva, Ph.D., Associate Professor, Biomedical Engineering, School of Energy, Environmental, Biological & Medical Engineering, University of Cincinnati. Mark J. Schulz, Ph.D. Professor, College of Engineering and Applied Science, School of Dynamic Systems; Mechanical Engineering, University Of Cincinnati 1 Abstract Damage to tissues in the central nervous system (CNS) and peripheral nervous system (PNS) is of serious concern since they possess a limited capacity to regenerate. A new generation of interventions centered on the essential element magnesium (Mg) offers a promising proposition to improve treatment options for nervous tissue trauma. The long-term goal of our research is to understand how ionic and metallic Mg can be used to therapeutically interact with CNS and PNS tissues. Initial experiments focused on studying the interaction between Mg ion (Mg2+) solutions and CNS-derived neural stem/progenitor cells (NSCs) in vitro. Latter studies focused on using Mg metal as a novel biomaterial in peripheral nerve (PN) tissue engineering. The use of Mg2+ solutions to treat traumatic brain injury (TBI) and stroke is well documented and shows tremendous promise in animal models; however, there are still obstacles to translating these findings into effective treatments for humans. When administered systemically, Mg2+ can attenuate a host of complex, harmful biochemical cascades that occur in CNS tissue in the hours and days after injury, though the exact mechanisms are still unclear. With this in mind, we sought to develop a culture system that would be responsive to changes in Mg2+ in an effort to better understand the interactions between Mg2+ and CNS tissue (in the form of NSCs). The central hypothesis of this work was that neural cells (NSCs) would show altered biological responses, including beneficial effects, to moderately elevated Mg2+ concentrations in vitro. Severe injuries to the PNS are also resistant to current treatment methods. There is a great clinical need for an engineered alternative to autografts, the current standard of treatment for management of nerve defects greater than 3 cm. It has been hypothesized that one of the principal reasons that nerve conduits are ineffective at bridging defects greater than 3 cm is that there is inadequate mechanical support for tissue regeneration in the lumen of the conduit. We proposed that metallic Mg, which has been shown to i be biocompatible and biodegradable in orthopedic and vascular applications, could serve as a physical support, a scaffold, within a nerve conduit. The central hypothesis of this work was that metallic Mg, placed in the lumen of a nerve conduit, would improve nerve regeneration by serving as a scaffold that would safely resorb into the body over time, after mechanical support was no longer required by regenerating tissue. The results from the research in this dissertation identify a culture system for studying Mg2+ supplementation using primary CNS-derived stem cells and present a novel use for metallic Mg as a biodegradable scaffold in PN tissue engineering. New methods for monitoring neural cell health in vitro are described, as are methods for monitoring the response of nerve tissue in the presence of Mg metal and the resorption of Mg metal surrounded by nerve tissue in situ. The findings of this research will contribute toward the development of more sophisticated culture systems for studying the interaction between neural cells and Mg2+ and also toward the further development of biodegradable metals as tissue engineering scaffolds for the improvement of PN tissue repair. ii iii Acknowledgements I would like to acknowledge the support given to me by parents, siblings, family, friends, mentors and peers over the last 5 years. The work presented in this document is the result of a tremendous, collaborative effort from a very strong team. I would especially like to acknowledge Tracy Hopkins, for taking the technical lead on these projects and educating me in many cell culture ‘tricks of the trade’; the undergraduate and graduate students who spent time in the Pixley lab contributing to these projects: Erin Armao, Andrea Bobadillo, Ami Cohen, John Galvin, Dr. Xuefei Guo, Ben Hogan, Dr. Julia Kuhlmann, John Mast and Chris Valentic; our surgeons: Dr. Matt Hershcovitch, Dr. Kevin Little and Dr. David Hom, our in vivo projects would not have been possible without your steady hands and generous support; and Kati LaSance, your skills with the microCT are amazing; thank you for providing us with so much good data! Thank you to our external collaborators, especially Danielle Minteer, Da-Tren Chou, Dr. Lauren Kokai and Dr. Kacey Marra from the University of Pittsburgh - your insight, instruction and materials support were invaluable to the success of our in vivo work. To the other students and faculty of the NSF ERC for Revolutionizing Metallic Biomaterials at the University of Cincinnati, the University of Pittsburgh, North Carolina A&T State University and Hannover Medical School, this journey would not have been half as special without your support and companionship. One Team, One Dream! I extend a special thanks to the esteemed faculty who generously agreed to serve on my committee: to Dr. Daria Narmoneva for her excellent mentorship in my undergraduate education and input on quantifying biological phenomena, to Dr. Joe Clark for providing an essential clinical perspective and Dr. Mark Schulz for taking time to share his outlook on the business of engineering and for his steadfast support of Student Leadership and Professional Development. It is with great respect and gratitude that I also thank my mentor, Dr. Sarah Pixley, for welcoming me into her lab and guiding me through this process over the iv last 4 years. Your unwavering drive for knowledge and passion for science are remarkable and this work would not have been possible without your relentless support, patience and superb instruction. Finally, to our sponsors, thank you: This research was supported by the lab of Dr. Sarah Pixley and the National Science Foundation Engineering Research Center for Revolutionizing Metallic Biomaterials (EEC-0812348 and NCAT 260116C supplement). v Table of Contents Abstract……………………………………….…………………………………….……………………...i Acknowledgements…………………………………….…………………………………….……...….…iv Table of Contents…………………………………….…………………………………….………………….........vi List of Figures..................………………….…………………………………….……………………....vii List of Tables....................………………….…………………………………….……………………..xvii 1.0 Introduction and Specific Aims…………………………………….……………………......…....1 2.0 Background……………………….…………………………………….……………………….10 3.0 Effects of Mg2+ supplementation of neural stem/progenitor cells in vitro…………………........59 4.0 Digital methods for evaluating cellular response to magnesium filaments………………….......86 in peripheral nerve tissue in vivo 5.0 Magnesium metal as a scaffolding material for peripheral nerve regeneration..........................126 6.0 Discussion and Conclusions….…………………………………….…………….....................165 References….…………………………………….…………….............................................................170 vi List of Figures Figure 1 Functional organization of the nervous system. Receptors in peripheral nerves send sensory information to the central nervous system via the afferent division of the peripheral nervous system. After processing in the central nervous system, motor commands travel out to distal target through the efferent division of the peripheral nervous system 1. .................................................................... 11 Figure 2 Neuron structure. The neuron is a complex, electrically excitable cell that is the principle functional building block of nervous tissues. Neurons communicate with other neurons and all other organ systems in the body to regulate the processes of life. Image from 2. ....................................... 13 Figure 3 Anatomy of the spinal cord. The spinal cord resides in, and is protected by, the vertebral column (A – Superior transverse view). Nerves project from the left and right sides to innervate the body (B). The ventral root carries motor commands from the CNS to the periphery whereas the dorsal root carries sensory information from the periphery to the spinal cord. Modified from 3. These views are in an upside-down position because that is the way that information comes in from an MRI machine scan. So ‘dorsal’ (toward the back) is actually down in this picture and ‘ventral’ (the belly side) is up 256. ...................................................................................................................................... 16 Figure 4 Nerve architecture. Nerve fibers (axons) are supported and encased in myelin by Schwann cells within the endoneurium. The
Recommended publications
  • What to Expect After Having a Subarachnoid Hemorrhage (SAH) Information for Patients and Families Table of Contents
    What to expect after having a subarachnoid hemorrhage (SAH) Information for patients and families Table of contents What is a subarachnoid hemorrhage (SAH)? .......................................... 3 What are the signs that I may have had an SAH? .................................. 4 How did I get this aneurysm? ..................................................................... 4 Why do aneurysms need to be treated?.................................................... 4 What is an angiogram? .................................................................................. 5 How are aneurysms repaired? ..................................................................... 6 What are common complications after having an SAH? ..................... 8 What is vasospasm? ...................................................................................... 8 What is hydrocephalus? ............................................................................... 10 What is hyponatremia? ................................................................................ 12 What happens as I begin to get better? .................................................... 13 What can I expect after I leave the hospital? .......................................... 13 How will the SAH change my health? ........................................................ 14 Will the SAH cause any long-term effects? ............................................. 14 How will my emotions be affected? .......................................................... 15 When should
    [Show full text]
  • What%Is%Epilepsy?%
    What%is%Epilepsy?% Epilepsy(is(a(brain(disorder(in(which(a(person(has(repeated(seizures((convulsions)(over(time.(Seizures(are( episodes(of(disturbed(brain(activity(that(cause(changes(in(attention(or(behavior.( Causes( Epilepsy(occurs(when(permanent(changes(in(brain(tissue(cause(the(brain(to(be(too(excitable(or(jumpy.( The(brain(sends(out(abnormal(signals.(This(results(in(repeated,(unpredictable(seizures.((A(single(seizure( that(does(not(happen(again(is(not(epilepsy.)( Epilepsy(may(be(due(to(a(medical(condition(or(injury(that(affects(the(brain,(or(the(cause(may(be( unknown((idiopathic).( Common(causes(of(epilepsy(include:( •Stroke(or(transient(ischemic(attack((TIA)( •Dementia,(such(as(Alzheimer's(disease( •Traumatic(brain(injury( •Infections,(including(brain(abscess,(meningitis,(encephalitis,(and(AIDS( •Brain(problems(that(are(present(at(birth((congenital(brain(defect)( •Brain(injury(that(occurs(during(or(near(birth( •Metabolism(disorders(present(at(birth((such(as(phenylketonuria)( •Brain(tumor( •Abnormal(blood(vessels(in(the(brain( •Other(illness(that(damage(or(destroy(brain(tissue( •Use(of(certain(medications,(including(antidepressants,(tramadol,(cocaine,(and(amphetamines( Epilepsy(seizures(usually(begin(between(ages(5(and(20,(but(they(can(happen(at(any(age.(There(may(be(a( family(history(of(seizures(or(epilepsy.( Symptoms( Symptoms(vary(from(person(to(person.(Some(people(may(have(simple(staring(spells,(while(others(have( violent(shaking(and(loss(of(alertness.(The(type(of(seizure(depends(on(the(part(of(the(brain(affected(and( cause(of(epilepsy.(
    [Show full text]
  • Brain Injury and Opioid Overdose
    Brain Injury and Opioid Overdose: Acquired Brain Injury is damage to the brain 2.8 million brain injury related occurring after birth and is not related to congenital or degenerative disease. This includes anoxia and hospital stays/deaths in 2013 hypoxia, impairment (lack of oxygen), a condition consistent with drug overdose. 70-80% of hospitalized patients are discharged with an opioid Rx Opioid Use Disorder, as defined in DSM 5, is a problematic pattern of opioid use leading to clinically significant impairment, manifested by meaningful risk 63,000+ drug overdose-related factors occurring within a 12-month period. deaths in 2016 Overdose is injury to the body (poisoning) that happens when a drug is taken in excessive amounts “As the number of drug overdoses continues to rise, and can be fatal. Opioid overdose induces respiratory doctors are struggling to cope with the increasing number depression that can lead to anoxic or hypoxic brain of patients facing irreversible brain damage and other long injury. term health issues.” Substance Use and Misuse is: The frontal lobe is • Often a contributing factor to brain injury. History of highly susceptible abuse/misuse is common among individuals who to brain oxygen have sustained a brain injury. loss, and damage • Likely to increase for individuals who have misused leads to potential substances prior to and post-injury. loss of executive Acute or chronic pain is a common result after brain function. injury due to: • Headaches, back or neck pain and other musculo- Sources: Stojanovic et al 2016; Melton, C. Nov. 15,2017; Devi E. skeletal conditions commonly reported by veterans Nampiaparampil, M.D., 2008; Seal K.H., Bertenthal D., Barnes D.E., et al 2017; with a history of brain injury.
    [Show full text]
  • Traumatic Brain Injury and Domestic Violence
    TRAUMATIC BRAIN INJURY AND DOMESTIC VIOLENCE Women who are abused often suffer injury to their head, neck, and face. The high potential for women who are abused to have mild to severe Traumatic Brain Injury (TBI) is a growing concern, since the effects can cause irreversible psychological and physical harm. Women who are abused are more likely to have repeated injuries to the head. As injuries accumulate, likelihood of recovery dramatically decreases. In addition, sustaining another head trauma prior to the complete healing of the initial injury may be fatal. Severe, obvious trauma does not have to occur for brain injury to exist. A woman can sustain a blow to the head without any loss of consciousness or apparent reason to seek medical assistance, yet display symptoms of TBI. (NOTE: While loss of consciousness can be significant in helping to determine the extent of the injury, people with minor TBI often do not lose consciousness, yet still have difficulties as a result of their injury). Many women suffer from a TBI unknowingly and misdiagnosis is common since symptoms may not be immediately apparent and may mirror those of mental health diagnoses. In addition, subtle injuries that are not identifiable through MRIs or CT scans may still lead to cognitive symptoms. What is Traumatic Brain Injury? Traumatic brain injury (TBI) is defined as an injury to the brain that is caused by external physical force and is not present at birth or degenerative. TBI can be caused by: • A blow to the head, o e.g., being hit on the head forcefully with object or fist, having one’s head smashed against object/wall, falling and hitting head, gunshot to head.
    [Show full text]
  • Traumatic Brain Injury (TBI)
    Traumatic Brain Injury (TBI) Carol A. Waldmann, MD raumatic brain injury (TBI), caused either by blunt force or acceleration/ deceleration forces, is common in the general population. Homeless persons Tare at particularly high risk of head trauma and adverse outcomes to TBI. Even mild traumatic brain injury can lead to persistent symptoms including cognitive, physical, and behavioral problems. It is important to understand brain injury in the homeless population so that appropriate referrals to specialists and supportive services can be made. Understanding the symptoms and syndromes caused by brain injury sheds light on some of the difficult behavior observed in some homeless persons. This understanding can help clinicians facilitate and guide the care of these individuals. Prevalence and Distribution recover fully, but up to 15% of patients diagnosed TBI and Mood Every year in the USA, approximately 1.5 with MTBI by a physician experience persistent Swings. million people sustain traumatic brain injury disabling problems. Up to 75% of brain injuries This man suffered (TBI), 230,000 people are hospitalized due to TBI are classified as MTBI. These injuries cost the US a gunshot wound and survive, over 50,000 people die from TBI, and almost $17 billion per year. The groups most at risk to the head and many subsequent more than 1 million people are treated in emergency for TBI are those aged 15-24 years and those aged traumatic brain rooms for TBI. In persons under the age of 45 years, 65 years and older. Men are twice as likely to sustain injuries while TBI is the leading cause of death.
    [Show full text]
  • Rapidly Progressive Tetraplegia and Cognitive Deterioration During Rehabilitation: a Case of Neurodegenerative Disease
    J Surg Med. 2019;3(1):100-102. Case report DOI: 10.28982/josam.454181 Olgu sunumu Rapidly progressive tetraplegia and cognitive deterioration during rehabilitation: A case of neurodegenerative disease Rehabilitasyon sırasında hızlı ilerleyen tetrapleji ve bilişsel bozulma: Bir nörodejeneratif hastalık olgusu Sevgi İkbali Afşar 1, Oya Ümit Yemişçi 1 1 Department of Physical Medicine and Abstract Rehabilitation, Baskent University, Human prion diseases are fatal, progressive neurodegenerative disorders caused by neurolytic pathogen proteins, called Faculty of Medicine, Ankara, Turkey prions. The most common human prion disease is sporadic Creutzfeldt-Jakob disease, with an approximate annual prevalence of 0.5-1 per million. The symptoms and signs include rapidly progressive dementia, ataxia, myoclonic ORCID ID of the authors SİA: 0000-0002-4003-3646 seizures, akinetic mutism and other neurological and neurobehavioral disorders. The clinical spectrum of Creutzfeldt- OÜY: 0000-0002-0501-5127 Jakob disease is highly variable; therefore it can be difficult to diagnose premortem. This article describes a 78-year- old woman who initially presented with difficulty walking and balance disorder. As a result of the evaluation, the patient was transferred to rehabilitation clinic, with a diagnosis of cervical spinal stenosis. During hospitalization, she showed progressive decline in gait and balance and deteriorated rapidly. The patient was considered to be probable sporadic Creutzfeldt-Jakob disease after further investigations. Keywords: Neurodegenerative disease, Creutzfeldt-Jakob disease, Rehabilitation Öz Corresponding author / Sorumlu yazar: İnsan prion hastalıkları, prionlar olarak adlandırılan nörolitik patojen proteinlerin neden olduğu ilerleyici Sevgi İkbali Afşar Address / Adres: Fevzi Cakmak Cad. 5. Sokak nörodejeneratif hastalıklardır. En yaygın insan prion hastalığı sporadik Creutzfeldt-Jakob hastalığı olup, yıllık No: 48, 06490, Ankara, Türkiye prevalansı yaklaşık milyonda 0.5-1'dir.
    [Show full text]
  • Guidelines for the Management of Severe Traumatic Brain Injury 4Th Edition
    Guidelines for the Management of Severe Traumatic Brain Injury 4th Edition Nancy Carney, PhD Oregon Health & Science University, Portland, OR Annette M. Totten, PhD Oregon Health & Science University, Portland, OR Cindy O'Reilly, BS Oregon Health & Science University, Portland, OR Jamie S. Ullman, MD Hofstra North Shore-LIJ School of Medicine, Hempstead, NY Gregory W. J. Hawryluk, MD, PhD University of Utah, Salt Lake City, UT Michael J. Bell, MD University of Pittsburgh, Pittsburgh, PA Susan L. Bratton, MD University of Utah, Salt Lake City, UT Randall Chesnut, MD University of Washington, Seattle, WA Odette A. Harris, MD, MPH Stanford University, Stanford, CA Niranjan Kissoon, MD University of British Columbia, Vancouver, BC Andres M. Rubiano, MD El Bosque University, Bogota, Colombia; MEDITECH Foundation, Neiva, Colombia Lori Shutter, MD University of Pittsburgh, Pittsburgh, PA Robert C. Tasker, MBBS, MD Harvard Medical School & Boston Children’s Hospital, Boston, MA Monica S. Vavilala, MD University of Washington, Seattle, WA Jack Wilberger, MD Drexel University, Pittsburgh, PA David W. Wright, MD Emory University, Atlanta, GA Jamshid Ghajar, MD, PhD Stanford University, Stanford, CA Reviewed for evidence-based integrity and endorsed by the American Association of Neurological Surgeons and the Congress of Neurological Surgeons. September 2016 TABLE OF CONTENTS PREFACE ...................................................................................................................................... 5 ACKNOWLEDGEMENTS .............................................................................................................................................
    [Show full text]
  • Influence of Mild Hypothermia on Hypoxic- Ischemic Brain Damage in the Immature Rat
    003 I-399X/s 113404-0525$03.00/0 PEDIATRIC RESEARCH Vol. 34. No. 4. 1993 Copyright fc 1993 lnternat~onalPedlatnc Research Foundat~on.Inc. Prrt~rc~drn Lr.S..4. Influence of Mild Hypothermia on Hypoxic- Ischemic Brain Damage in the Immature Rat J. YAGER. J. TOWFIGHI. AND R. C. VANNUCCl Di,puritno~ic~l'Pi~cliciirii~.s /J. Y/. Roj.ul L'nivcrsii! IIo.spiiul. L'ni~~c,r.sii!*c~f'Su.sX.uic~lrc~~~~ut~, Su.skuioot~. Su.sku~chc~c~ut~,C'ut~udu. S7N 0x0: and D(~purrtnenrc~f'Purhol~~s.!~ (Nnrroputllok~g~ /J. T.1 und Pc~diuiricA'~,r~ro/ox~~ /R.('. I,./. 7%i, .l/iliot~S. Ilcr.sl~c,!~hI(~dicu1 ('cwrc~r. Tlli. Pi~t~n.s~-l~~unicrSiurc Crni~~c,r.vit!~. IIi~r.s/rc~~~.Pc~t~t~.s~~/vut~iu 17033 ABSTRACT. Recent studies in adult animals have shown mia also is protective (8. 9). Conversely. hyperthermia either that even small decreases in brain or core temperature during or after an hypoxic-ischemic insult worsens ultimate brain ameliorate the damage resulting from hypoxic-ischemic damage (lo, l I). insults. To determine the effect of minor reductions in In contrast to the adult. the human term infant. under physi- ambient temperature either during or after an hypoxic- ologic circumstances can maintain thermal neutrality only over ischemic insult on the brain of the immature rat, 7-d- a severely restricted range of environmental temperatures ( 12- postnatal rat pups underwent unilateral common carotid 15). Infants, who are frequently exposed to a variety of "stresses" artery ligation followed by exposure to hypoxia in 8% (birth asphyxia.
    [Show full text]
  • Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives
    International Journal of Molecular Sciences Review Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives Diji Kuriakose and Zhicheng Xiao * Development and Stem Cells Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC 3800, Australia; [email protected] * Correspondence: [email protected] Received: 29 September 2020; Accepted: 13 October 2020; Published: 15 October 2020 Abstract: Stroke is the second leading cause of death and a major contributor to disability worldwide. The prevalence of stroke is highest in developing countries, with ischemic stroke being the most common type. Considerable progress has been made in our understanding of the pathophysiology of stroke and the underlying mechanisms leading to ischemic insult. Stroke therapy primarily focuses on restoring blood flow to the brain and treating stroke-induced neurological damage. Lack of success in recent clinical trials has led to significant refinement of animal models, focus-driven study design and use of new technologies in stroke research. Simultaneously, despite progress in stroke management, post-stroke care exerts a substantial impact on families, the healthcare system and the economy. Improvements in pre-clinical and clinical care are likely to underpin successful stroke treatment, recovery, rehabilitation and prevention. In this review, we focus on the pathophysiology of stroke, major advances in the identification of therapeutic targets and recent trends in stroke research. Keywords: stroke; pathophysiology; treatment; neurological deficit; recovery; rehabilitation 1. Introduction Stroke is a neurological disorder characterized by blockage of blood vessels. Clots form in the brain and interrupt blood flow, clogging arteries and causing blood vessels to break, leading to bleeding.
    [Show full text]
  • Understanding Seizures and Epilepsy
    Understanding Sei zures & Epilepsy Selim R. Benbadis, MD Leanne Heriaud, RN Comprehensive Epilepsy Program Table of Contents * What is a seizure and what is epilepsy?....................................... 3 * Who is affected by epilepsy? ......................................................... 3 * Types of seizures ............................................................................. 3 * Types of epilepsy ............................................................................. 6 * How is epilepsy diagnosed? .......................................................... 9 * How is epilepsy treated? .............................................................. 10 Drug therapy ......................................................................... 10 How medication is prescribed ............................................ 12 Will treatment work?............................................................ 12 How long will treatment last?............................................. 12 Other treatment options....................................................... 13 * First aid for a person having a seizure ....................................... 13 * Safety and epilepsy ....................................................................... 14 * Epilepsy and driving..................................................................... 15 * Epilepsy and pregnancy ............................................................... 15 * More Information .......................................................................... 16 Comprehensive
    [Show full text]
  • Bleeding in the Brain: Haemorrhagic Stroke
    Call the Stroke Helpline: 0303 3033 100 or email: [email protected] Bleeding in the brain: haemorrhagic stroke A stroke due to bleeding in or around the brain is known as a haemorrhagic stroke. This guide explains the different types of stroke caused by bleeding, and how they are diagnosed and treated. What is a haemorrhagic stroke? 1. Bleeding within the brain If blood leaks from a blood vessel in When an artery inside the brain bursts it is or around the brain, this is called a called an intracerebral haemorrhage. About haemorrhagic stroke. You may also hear it 10% of all strokes are of this type. The called a brain haemorrhage or a brain bleed. blood leaks out into the brain tissue at high pressure, killing brain cells and causing brain In the UK, around 15% of strokes are swelling. haemorrhagic (due to a bleed), and about 85% are ischaemic (due to a blockage to the 2. Bleeding on the surface of the blood supply in the brain). brain Haemorrhagic stroke tends to affect The brain sits inside a fluid-filled cushion of younger people than ischaemic stroke, and membranes that protects it from the skull, is most common in people aged between called the subarachnoid space. If blood 45 and 70. Most strokes in the UK happen vessels near the surface of the brain burst over the age of 70. and blood leaks into the subarachnoid space, this is called a subarachnoid haemorrhage There are two main types of haemorrhagic (SAH). stroke: SAH accounts for around 5% of all strokes, 1.
    [Show full text]
  • Part Ii – Neurological Disorders
    Part ii – Neurological Disorders CHAPTER 19 HEAD AND SPINAL INJURY Dr William P. Howlett 2012 Kilimanjaro Christian Medical Centre, Moshi, Kilimanjaro, Tanzania BRIC 2012 University of Bergen PO Box 7800 NO-5020 Bergen Norway NEUROLOGY IN AFRICA William Howlett Illustrations: Ellinor Moldeklev Hoff, Department of Photos and Drawings, UiB Cover: Tor Vegard Tobiassen Layout: Christian Bakke, Division of Communication, University of Bergen E JØM RKE IL T M 2 Printed by Bodoni, Bergen, Norway 4 9 1 9 6 Trykksak Copyright © 2012 William Howlett NEUROLOGY IN AFRICA is freely available to download at Bergen Open Research Archive (https://bora.uib.no) www.uib.no/cih/en/resources/neurology-in-africa ISBN 978-82-7453-085-0 Notice/Disclaimer This publication is intended to give accurate information with regard to the subject matter covered. However medical knowledge is constantly changing and information may alter. It is the responsibility of the practitioner to determine the best treatment for the patient and readers are therefore obliged to check and verify information contained within the book. This recommendation is most important with regard to drugs used, their dose, route and duration of administration, indications and contraindications and side effects. The author and the publisher waive any and all liability for damages, injury or death to persons or property incurred, directly or indirectly by this publication. CONTENTS HEAD AND SPINAL INJURY 413 EPIDEMIOLOGY � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �
    [Show full text]